Purpose: The aim of the present study was to investigate the changes occurring in leukocyte levels of reactive oxygen species (ROS) and total blood plasma antioxidant capacity (TAS) as a result of a marathon/half-marathon race.

Methods: Fourteen men participating in the Oslo Marathon 2000 and 8 women and 8 men participating in the Oslo Half-Marathon 2001 were recruited to the study. Flow cytometry and the ROS-sensitive probe dihydroethidium (DHE) were used to study the intracellular levels of ROS in circulating leukocytes. Both basal ROS levels as well as the capacity of leukocytes to respond with ROS synthesis upon a defined in vitro stimulus, i.e., phorbol myristate acetate (PMA) was assessed before and immediately after the races. TAS was measured using the ABTS+ reduction assay kit.

Results: The basal levels of ROS in leukocytes were either not significantly changed (men, 3-25% reduced) or reduced 33% (women, P < 0.01) as a result of the marathon/half-marathon race. After the marathon race, the capacity of leukocytes to produce ROS upon PMA stimulation was reduced, i.e., 6% (granulocytes) (P < 0.001) and 23% (monocytes) (P < 0.01) residual capacity compared with the prerace situation. A 22-30% reduction (P < 0.05) in monocyte ROS response was seen also as a result of the half-marathon race, whereas the granulocyte ROS response was maintained at the prerace level (19% (women) and 15% (men) reduction, NS)). TAS increased significantly (11-19%, P < 0.05) after both races.

Conclusions: The present results indicate an exhaustion of leukocyte ROS-generating mechanisms after prolonged strenuous exercise. This may partly explain the observation that athletes are more sensitive to attract infectious diseases if exposed to pathogenic micro-organisms during the immediate period after intensive physical activity.

Download full-text PDF

Source
http://dx.doi.org/10.1249/01.MSS.0000106168.12113.95DOI Listing

Publication Analysis

Top Keywords

capacity leukocytes
12
ros
8
result marathon/half-marathon
8
men participating
8
participating oslo
8
levels ros
8
ros response
8
capacity
5
leukocytes
5
marathon running
4

Similar Publications

IL-35 modulates Tfh2 and Tfr cell balance to alleviate allergic rhinitis.

Inflamm Res

January 2025

Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China.

Background: Allergic rhinitis (AR) represents a persistent inflammatory condition affecting the upper respiratory tract, characterized by abnormal initiation of the immunoglobulin E (IgE)-mediated cascade. Follicular helper T (Tfh) cells and regulatory T (Tfr) cells are pivotal in orchestrating the development of IgE production in AR patients. IL-35, an anti-inflammatory cytokine, secreted by various cellular subpopulations.

View Article and Find Full Text PDF

Neutrophils were historically considered a homogenous population of cells with functions limited to innate immunity against external threats. However, with the rise of immunotherapy, recent works have shown that neutrophils are also important actors in immuno-oncology. In this context, neutrophils appear as a more heterogenous population of cells.

View Article and Find Full Text PDF

Ex vivo assessment of human neutrophil motility and migration.

Methods Cell Biol

January 2025

Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands; Oncode Institute, Utrecht, The Netherlands. Electronic address:

Neutrophils are pivotal in orchestrating tumor-induced systemic inflammation and are increasingly recognized for their critical involvement in both the initiation and progression of cancer. A fundamental facet of neutrophil biology is their migratory capacity, which enables them to extravasate and infiltrate tumors in other tissues, where they carry out essential effector functions. Unraveling the intricate mechanisms of neutrophil motility and migration is crucial for comprehending immune responses and inflammatory processes, shedding light on their substantial contribution to cancer progression.

View Article and Find Full Text PDF

CD4FOXP3Exon2 regulatory T cell frequency predicts breast cancer prognosis and survival.

Sci Adv

January 2025

Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", IEOS-CNR, Napoli, Italy.

CD4FOXP3 regulatory T cells (T) suppress immune responses to tumors, and their accumulation in the tumor microenvironment (TME) correlates with poor clinical outcome in several cancers, including breast cancer (BC). However, the properties of intratumoral T remain largely unknown. Here, we found that a functionally distinct subpopulation of T, expressing the FOXP3 Exon2 splicing variants, is prominent in patients with hormone receptor-positive BC with poor prognosis.

View Article and Find Full Text PDF

Early-onset (EOCC) and late-onset cervical cancers (LOCC) represent two clinically distinct subtypes, each defined by unique clinical manifestations and therapeutic responses. However, their immunological profiles remain poorly explored. Herein, we analyzed single-cell transcriptomic data from 4 EOCC and 4 LOCC samples to compare their immune architectures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!